BMS-690514

DRUG6 trials

Sponsors

Bristol-Myers Squibb

Conditions

Breast CancerCancerCancer (Solid Tumors)Non Small Cell Lung CancerNon-Small-Cell Lung CarcinomaTumor

Phase 1

A Phase I Study of BMS-690514 in Patients With Advanced or Metastatic Solid Tumors

CompletedNCT00329004

Bristol-Myers SquibbCancer, Tumor

Start: 2006-08-31End: 2009-07-31Updated: 2011-01-25

A Phase I Study of BMS-690514 in Combination With Paclitaxel and Carboplatin

CompletedNCT00420186

Bristol-Myers SquibbCancer (Solid Tumors)

Start: 2007-10-31End: 2012-02-29Updated: 2016-09-30

Phase I Study of BMS-690514 in Japanese Patients With Solid Tumors

CompletedNCT00516451

Bristol-Myers SquibbCancer

Start: 2007-11-30End: 2008-07-31Updated: 2008-10-13

Phase 2

A Comparison Between BMS-690514 and Erlotinib in Patients Who Were Previously Treated for NSCLC

CompletedNCT00743938

Bristol-Myers SquibbNon Small Cell Lung Cancer

Start: 2009-03-31End: 2012-06-30Updated: 2015-10-12

Efficacy and Safety of BMS-690514 in Combination With Letrozole to Treat Metastatic Breast Cancer

CompletedNCT01068704

Bristol-Myers SquibbBreast Cancer

Start: 2010-06-30End: 2010-12-31Updated: 2015-10-12

Trial of BMS-690514 in Non-Small Cell Lung Cancer Subjects Who Have Been Treated With Gefitinib or Erlotinib and Are Genotypically EGFR Mutation Positive or Who Have Had a Prior Response

CompletedNCT01167244

Bristol-Myers SquibbNon-Small-Cell Lung Carcinoma

Start: 2010-08-31End: 2011-04-30Updated: 2015-10-12

Related Papers

A phase I study of BMS-690514 in Japanese patients with advanced or metastatic solid tumors.

2012-08-103 citations